Your browser doesn't support javascript.
loading
Different components of excessive daytime sleepiness and the change with positive airway pressure treatment in patients with obstructive sleep apnea: Results from the Icelandic Sleep Apnea Cohort (ISAC).
Thorarinsdottir, Elin H; Janson, Christer; Aspelund, Thor; Benediktsdottir, Bryndis; Júlíusson, Sigurður; Gislason, Thorarinn; Kuna, Samuel T; Pack, Allan I; Keenan, Brendan T.
Afiliação
  • Thorarinsdottir EH; Primary Health Care of the Capital Area, Reykjavik, Iceland.
  • Janson C; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Aspelund T; Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
  • Benediktsdottir B; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Júlíusson S; Icelandic Heart Association, Kopavogur, Iceland.
  • Gislason T; Primary Health Care of the Capital Area, Reykjavik, Iceland.
  • Kuna ST; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Pack AI; Ear, Nose and Throat (ENT) Department, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Keenan BT; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
J Sleep Res ; 31(3): e13528, 2022 06.
Article em En | MEDLINE | ID: mdl-34862685
ABSTRACT
Excessive daytime sleepiness includes both an inability to stay awake during the day and a general feeling of sleepiness. We describe different dimensions of daytime sleepiness in adults with moderate-severe obstructive sleep apnea (OSA) before and after 2 years of positive airway pressure (PAP) treatment. Using the Epworth Sleepiness Scale (score >10 defined as "risk of dozing") and Basic Nordic Sleep Questionnaire (feeling sleepy ≥3 times/week defined as "feeling sleepy"), participants were categorised into sleepiness phenotypes labelled non-sleepy, risk of dozing only, feeling sleepy only, or both symptoms. Participants repeated baseline assessments and PAP adherence was evaluated after 2 years. PAP-adherent subjects with sleepiness symptoms at both baseline and follow-up were considered persistently sleepy. Of the 810 participants, 722 (89%) returned for follow-up. At baseline, 17.7% were non-sleepy, 7.7% were at risk of dozing only, 24.7% were feeling sleepy only, and 49.9% had both symptoms. PAP adherence did not differ by baseline sleepiness phenotype. Patients with risk of dozing demonstrated greater PAP benefits for sleepiness symptoms than non-sleepy and feeling sleepy only phenotypes. Using these phenotypes, 42.3% of PAP users had persistent sleepiness; they had less severe OSA (p < 0.001), more persistent OSA symptoms and more often had symptoms of insomnia than patients in whom sleepiness resolved. Our present results, therefore, suggest that measuring the risk of dozing and the feeling of sleepiness reflect different sleepiness components and may respond differently to PAP. Patients feeling sleepy without risk of dozing may need more thorough evaluation for factors contributing to sleepiness before initiating treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Distúrbios do Sono por Sonolência Excessiva Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Distúrbios do Sono por Sonolência Excessiva Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article